2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours

M.S. Aapro, J. Bohlius, David A. Cameron, Lissandra Dal Lago, J. Peter Donnelly, N. Kearney, G. H. Lyman, R. Pettengell, V. C. Tjan-Heijnen, J. Walewski, Damien C. Weber, C. Zielinski

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)8-32
JournalEuropean Journal of Cancer
Volume47
Issue number1
DOIs
Publication statusPublished - Jan 2011

Keywords

  • Antineoplastic agents
  • Filgrastim
  • Granulocyte colony-stimulating factor
  • Lenograstim
  • Neoplasms
  • Neutropenia
  • Pegfilgrastim
  • Guideline

Cite this